Melissa A Penny Robert Verity Caitlin A Bever Christophe Sauboin Katya Galactionova Stefan Flasche Michael T White Edward A Wenger Nicolas Van de Velde Peter Pemberton-Ross Jamie T Griffin Thomas A Smith Philip A Eckhoff Farzana Muhib Mark Jit Azra C Ghani
10.1016/S0140-6736(15)00725-4
Lancet
2016 Jan 23;387(10016):367-375.
CC BY
https://pubmed.ncbi.nlm.nih.gov/26549466/
Malaria Vaccines / economics Malaria, Falciparum / prevention & control Models, Theoretical Public Health
Malaria Vaccines / economics Malaria, Falciparum / prevention & control Models, Theoretical Public Health Research Support, Non-U.S. Gov't Africa / epidemiology Clinical Trials, Phase III as Topic Cost-Benefit Analysis Humans Immunization Schedule Infant Malaria Vaccines / administration & dosage Malaria, Falciparum / economics Malaria, Falciparum / epidemiology Multicenter Studies as Topic Malaria Vaccines
PMC4723722
26549466
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
2016